The online distribution of prescription‐only pharmaceutical products raises serious legal and regulatory issues, including how governments, agencies, or organizations will regulate and monitor such activities, particularly when the distributors are offshore Web sites. This paper discusses the current regulatory environment for marketing prescription‐only drugs online and distributing them across national borders, along with product liability issues. Four hypothetical scenarios focus on key legal and regulatory issues.
Spain, J.W., Siegel, C.F. and Ramsey, R.P. (2001), "Selling drugs online: distribution‐related legal/regulatory issues", International Marketing Review, Vol. 18 No. 4, pp. 432-449. https://doi.org/10.1108/EUM0000000005935Download as .RIS
MCB UP Ltd
Copyright © 2001, MCB UP Limited